AG
HZNP

AlphaSimPlex Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

AlphaSimPlex Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,301
Closed -$304K – 277
2021
Q1 		$304K Hold
3,301
– – 0.13% 234
2020
Q4 		$241K Sell
3,301
-768
-19% -$57.1K 0.08% 289
2020
Q3 		$316K Buy
+4,069
New +$280K 0.14% 252

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AlphaSimPlex Group's HZNP Position: Q2 2021 in Review

AlphaSimPlex Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2021, closing a stake of 3,301 shares — an estimated $304K sold.

AlphaSimPlex Group first reported a position in HZNP in Q3 2020 and held it in 3 quarters. The position peaked at $316K in Q3 2020. 526 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

  • AlphaSimPlex Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • AlphaSimPlex Group sold 3,301 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2021, an estimated $304K.
  • AlphaSimPlex Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 3 quarters.
  • AlphaSimPlex Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $316K in Q3 2020.
  • 526 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on AlphaSimPlex Group's 13F filing for Q2 2021, filed 12 Aug 2021.